Basis of Presentation (Tables)

3 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The table below sets forth the share-based awards that have been excluded from the computation of diluted earnings per share because their effect would be anti-dilutive:

	Three Months Ended March 31,
	2024	2023
Anti-Dilutive Restricted Stock Units	84	67,420
Anti-Dilutive Performance Share Units	—	1,854
	84	69,274

Schedule of Earnings Per Share, Basic and Diluted

The computations for basic and dilutive earnings per share are as follows:

Dollars in thousands, except per share data	Three Months Ended March 31,
	2024		2023
Numerator:
Net Income	$	101,891	$	230,377
Denominator:
Weighted-average shares of common stock outstanding	29,951,109		34,535,268
Effect of dilutive shares	122,553		616,333
Weighted-average diluted shares of common stock outstanding	30,073,662		35,151,601
Earnings per Share:
Basic	$	3.40	$	6.67
Dilutive	$	3.39	$	6.55